ALLK - Allakos Inc. Market Value

Official company branding of Allakos (ALLK)

Current price action for Allakos Inc. (ALLK), with a market capitalization recorded at 0.03, reflects the business trajectory of a company implementing ESG bioethical standards in antibody development. The scientific community values Allakos Inc. (ALLK) for its innovative methods of combating severe allergies by targeting mast cells. Anticipation of the interim test results for gastrointestinal drugs will provide a new catalyst, as previous losses in the project portfolio are already priced in.

ALLK Allakos Inc: Market Capitalization in the range 07/04/2022 - 05/24/2025

Comprehensive metric breakdowns and analytics for allakos.com (ALLK)

- market price and analyst price targets:
Price Chart Allakos|ALLK - Price Target Chart
- market capitalization statistics:
Market Value ALLK|ALLK - Total Company Value
- book value of equity indicators:
Net Assets per Single Share Allakos|ALLK - Book Capitalization|Market Value to Book Value Ratio allakos.com|ALLK - Total Asset Value of Company
- business debt structure and liquidity details:
Total Debt to Capital Allakos Inc.|ALLK - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Allakos|ALLK - Company Aggregate Debts|Debt to Book Capitalization Ratio ALLK|ALLK - Company Long-Term Loans and Borrowings|Company Short-Term Debt Allakos|Quick Ratio allakos.com
- business earnings and investment ratios data:
ALLK - Net Profit|Future Profit Allakos Inc.|ALLK - Company Value to Net Income|Forward P/E Multiple Allakos|ALLK - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ALLK|ALLK - Operating profit before deduction of amortization|Earnings per share for the last twelve months Allakos|ALLK - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months allakos.com|ALLK - Earnings growth in current year|Net earnings per share growth forecast for next year Allakos Inc.
Fundamental company analysis:ALLK (Allakos Therapeutics)
Product sample of allakos.com

The price action of Allakos Inc. (ALLK) directly reflects the market valuation of its potential in allergy therapy. This indicator is calculated as the product of the current share price and the total number of outstanding securities. By analyzing the company's weighted market capitalization, an investor sees the aggregate business volume in real-time. For biopharmaceuticals, this metric capitalizes expectations regarding antibody implementation and insurance payouts. The result allows for the rapid identification of asset overheating between quarterly reports.

Key competitors

Market Value argenx ARGX|BioNTech Inc. - Market Value|ABVX - Market Value|ADMA: Market Value|Protagonist Therapeutics (PTGX) - Market Value|immunovant.com (IMVT) - Market Capitalization|Market Value Kiniksa|Grifols SA - Market Valuation|Market Capitalization ADPT|CLDX (Celldex Corp) - Market Value|Market Capitalization AUPH (Aurinia Pharmaceuticals)|Market Capitalization biocryst.com BCRX|VERA - Market Value|Market Value DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp (PHVS) - Market Value|Market Valuation AbCellera Biologics Inc.|TRML (Tourmaline Bio, Inc.) - Market Capitalization|Market Capitalization precigen.com|Market Valuation PHAR (Pharming Group)|NKTR (Nektar Therapeutics Inc) - Market Value|Market Capitalization UPB (Upstream Bio Corp)|Market Capitalization Zenas Corp (ZBIO)|IMNM - Market Value|gossamerbio.com (GOSS) - Market Valuation|KalVista Pharmaceuticals, Inc. (KALV) - Market Value|Market Valuation Septerna, Inc.|Market Valuation PVLA|Market Capitalization Savara Pharma|Market Value Rigel Pharmaceuticals (RIGL)|anaptysbio.com - Market Capitalization|Market Capitalization ATXS (Astria Therapeutics, Inc.)|enGene Holdings Inc (ENGN) - Market Value|RAPT Therapeutics - Market Capitalization|JBIO - Market Capitalization|Aclaris Therapeutics (ACRS) - Market Value|KYTX (kyvernatx.com) - Market Value|Market Value Tiziana Life Sciences Ltd|Market Value CABA|Market Capitalization VTYX|Market Capitalization Theratechnologies, Inc (THTX)|Market Value Avalo Therapeutics, Inc AVTX|Market Capitalization eledon.com ELDN|AGEN - Market Value|Market Value Climb Bio Inc.|Zura Bio (ZURA) - Market Value|ATYR - Market Capitalization|Market Valuation ADAG|IMA: Market Value|Market Capitalization STTK|Market Capitalization equilliumbio.com|Market Value Connect Biopharma Holdings Limited CNTB|IMUX: Market Capitalization|Atara Biotherapeutics Inc - Market Capitalization|InflaRx N.V. (IFRX) - Market Valuation|XFOR (X4 Pharmaceuticals, Inc.) - Market Valuation|ACET - Market Capitalization|CELU (Celularity Inc) - Market Capitalization|Market Capitalization INmune Bio Corporation|Market Value Barinthus Biotherapeutics (BRNS)|Market Value KZR (kezarlifesciences.com)|Market Value SAB Biotherapeutics, Inc. SABS|Akari Therapeutics PLC - Market Value|ENLV - Market Value|QTTB - Market Capitalization|GeoVax Labs, Inc. (GOVX) - Market Value|Market Valuation EDSA (edesabiotech.com)|IBIO (iBio) - Market Capitalization|CARM: Market Value|Market Capitalization XTLB|Market Capitalization boltbio.com (BOLT)|Market Value HCW Biologics HCWB|Market Value APVO|AIM - Market Value|Aditxt (ADTX) - Market Valuation|GRI: Market Capitalization|XORTX Corp (XRTX) - Market Capitalization|Market Valuation HIND|REVB: Market Value|Market Capitalization INDP|Market Capitalization Scinai Immunotherapeutics Ltd|Market Value CalciMedica CALI|AFMD - Market Valuation|HOOK - Market Value|IGM Biosciences, Inc. (IGMS) - Market Valuation|ITOS (iTeos Therapeutics, Inc.) - Market Valuation|Ocean Biomedical Inc (OCEA) - Market Capitalization|Market Value TC BioPharm (Holdings) PLC|Market Capitalization THRD (Third Harmonic Bio Inc)